LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Perrigo Co PLC

Suletud

SektorTervishoid

10.66 2.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.35

Max

10.86

Põhinäitajad

By Trading Economics

Sissetulek

1B

-390M

Müük

-140M

969M

Aktsiakasum

0.43

Dividenditootlus

10.5

Kasumimarginaal

-40.229

Töötajad

8,100

EBITDA

1.4B

118M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+62.52% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

10.50%

2.38%

Järgmine tulemuste avaldamine

5. aug 2026

Järgmine dividendimakse kuupäev

16. juuni 2026

Järgmine aktsia dividendi kuupäev (ex-date)

28. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-79M

1.5B

Eelmine avamishind

8.45

Eelmine sulgemishind

10.66

Uudiste sentiment

By Acuity

39%

61%

118 / 344 Pingereas Healthcare

Perrigo Co PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. juuli 2025, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14. juuli 2025, 12:33 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14. juuli 2025, 12:33 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14. juuli 2025, 12:32 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14. juuli 2025, 12:31 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14. juuli 2025, 12:31 UTC

Omandamised, ülevõtmised, äriostud

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14. juuli 2025, 12:30 UTC

Omandamised, ülevõtmised, äriostud

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Võrdlus sarnastega

Hinnamuutus

Perrigo Co PLC Prognoos

Hinnasiht

By TipRanks

62.52% tõus

12 kuu keskmine prognoos

Keskmine 17 USD  62.52%

Kõrge 17 USD

Madal 17 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Perrigo Co PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

118 / 344 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
help-icon Live chat